Nova Financial’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.45K Buy
+171
New +$2.22K ﹤0.01% 736

Other funds holding FDMT

Nova Financial's FDMT Position: Q3 2026 in Review

Nova Financial opened a new position in 4D Molecular Therapeutics (FDMT) in Q3 2026: 171 shares worth $2.45K. The stake represents ﹤0.01% of the portfolio and ranks #736 among its holdings.

166 funds tracked by Wall St. Rank hold FDMT as of Q3 2026.

  • Nova Financial held 171 shares of 4D Molecular Therapeutics worth $2.45K as of Q3 2026.
  • 4D Molecular Therapeutics was a new Nova Financial position in Q3 2026.
  • 4D Molecular Therapeutics made up ﹤0.01% of Nova Financial's portfolio in Q3 2026, its #736 holding.
  • 166 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q3 2026.

Based on Nova Financial's 13F filing for Q3 2026, filed 4 Nov 2026.